A Study to Investigate the Effect of AZD0780 on Metformin Pharmacokinetics in Healthy Adult Volunteers Aged 18 to 55 Years

• Status: NOT_YET_RECRUITING
• Trial end date: 2025-12-29

Summary

The purpose of this study is to determine how the experimental medication AZD0780 impacts the pharmacokinetics (PK) of metformin, a common medication used to treat type 2 diabetes mellitus, when given together in healthy participants.

• Phase: PHASE1

Details

• Lead Sponsor: AstraZeneca
• Collaborator: Parexel
• Treatments: Metformin